Yaribeygi H, Maleki M, Jamialahamdi T, Moallem SA, Sahebkar A. Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders. EXCLI J. [Internet]. 2023 Apr. 21 [cited 2024 Apr. 30];22:403-14. Available from: https://www.excli.de/index.php/excli/article/view/6022